Sep 18, 2013, 02.39 PM IST | Source: CNBC-TV18

Sell Sun Pharma, may fall to Rs 520: Vayalar

Manoj Murlidharan Vayalar of IIFL recommends selling Sun Pharmaceutical Industries with a target of Rs 520 and a stoploss at Rs 555.

Manoj Murlidharan

Head- Derivatives, Religare Securities

Expertise : F&O

More about the Expert...

Manoj Murlidharan Vayalar of IIFL told CNBC-TV18, "We are negative on pharmaceutical stocks and we feel Sun Pharmaceutical Industries is showing good distribution in the last three-four sessions on the cash market. So it is a sell from our side with a stoploss of Rs 555. We are expecting a good move on the downside somewhere close to Rs 520."

At 14:12 hrs Sun Pharmaceutical Industries was quoting at Rs 544.55, up Rs 0.20, or 0.04 percent. It has touched an intraday high of Rs 550 and an intraday low of Rs 535.55.

The share touched its 52-week high Rs 583 and 52-week low Rs 344.73 on 16 September, 2013 and 15 November, 2012, respectively. Currently, it is trading 6.6 percent below its 52-week high and 57.96 percent above its 52-week low. Market capitalisation stands at Rs 112,785.23 crore.

Disclosure: We have discussed this with our clients but no personal holdings.

Set email alert for


Buy & sell politicians on Power Play
- the political stock exchange

Price Update

Arvind Kejriwal

1716.75 10.45 0.61%


Bought today


Sold today


User holding

video of the day

Ambit Cap eyes two years of market cheer; bets on cyclicals

Explore Moneycontrol

Copyright © Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of is prohibited.